Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681759 · ClinicalTrials.gov registry record
An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 1,836
- Enrollment target
NCT00681759: Completed study, sponsored by AstraZeneca.
NCT00681759 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 1,836 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681759 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 1,836 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,836 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-09 |
What the finished NCT00681759 record still lists
NCT00681759 is an observational study that tracks outcomes without assigning an intervention. Its 1,836 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00681759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00681759 about?
NCT00681759 is a clinical study titled "An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients". The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin
What is the current status of trial NCT00681759?
This trial is currently completed. The enrollment target is 1,836 participants. The study started on 2008-01. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00681759?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia